US Patent Issued to Atai Therapeutics on July 8 for "Dimethoxyphenylalkylamine activators of serotonin receptors" (California Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,537, issued on July 8, was assigned to Atai Therapeutics Inc. (New York).

"Dimethoxyphenylalkylamine activators of serotonin receptors" was invented by Glenn Short (Encinitas, Calif.), Robert B. Perni (Encinitas, Calif.), Benjamin Robert Difrancesco (Encinitas, Calif.) and Tanweer A. Khan (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I), or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of usi...